Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(17):1191; doi:10.1093/jnci/djn314
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

In This Issue

The first 10% of the full text of this article appears below.

Nonmelanoma Skin Cancer and Risk for Subsequent Cancers

People with a personal history of nonmelanoma skin cancer (NMSC) may have an increased risk of subsequent malignancies other than NMSC. Chen et al. (p. 1215) investigated this association in a community-based, prospective cohort study with a 16-year follow-up. The crude incidence of cancer was 293.5 per 10,000 person-years among individuals with a personal history of NMSC but only 77.8 per 10,000 person-years among those without such a history. The risk of a subsequent malignancy other than NMSC was two times greater among those with a personal history of NMSC than among . . . [Full Text of this Article]

Antihypertensive Agents and Chemoprevention of Skin Cancer

A New Method to Evaluate Cancer Therapies Faster

Candidaspongiolide, a potential anticancer drug from sponges

A Mouse Model for Leukemia Pathogenesis

Mutation in a Gene Encoding a Mitochondrial Enzyme and RCC


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Induction of Apoptosis in Human Cancer Cells by Candidaspongiolide, a Novel Sponge Polyketide
Daniela Trisciuoglio, Badarch Uranchimeg, John H. Cardellina, Tamara L. Meragelman, Shigeki Matsunaga, Nobuhiru Fusetani, Donatella Del Bufalo, Robert H. Shoemaker, and Giovanni Melillo
J Natl Cancer Inst 2008 100: 1233-1246. [Abstract] [Full Text] [PDF]

Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor Genes
Mei-Yi Wu, Karen W. Eldin, and Arthur L. Beaudet
J Natl Cancer Inst 2008 100: 1247-1259. [Abstract] [Full Text] [PDF]

Germline SDHB Mutations and Familial Renal Cell Carcinoma
Christopher Ricketts, Emma R. Woodward, Pip Killick, Mark R. Morris, Dewi Astuti, Farida Latif, and Eamonn R. Maher
J Natl Cancer Inst 2008 100: 1260-1262. [Abstract] [Full Text] [PDF]

Nonmelanoma Skin Cancer and Risk for Subsequent Malignancy
Jiping Chen, Ingo Ruczinski, Timothy J. Jorgensen, Gayane Yenokyan, Yin Yao, Rhoda Alani, Nanette J. Liégeois, Sandra C. Hoffman, Judith Hoffman-Bolton, Paul T. Strickland, Kathy J. Helzlsouer, and Anthony J. Alberg
J Natl Cancer Inst 2008 100: 1215-1222. [Abstract] [Full Text] [PDF]

Association of ACE Inhibitors and Angiotensin Receptor Blockers with Keratinocyte Cancer Prevention in the Randomized VATTC Trial
Jennifer B. Christian, Kate L. Lapane, Anne L. Hume, Charles B. Eaton, and Martin A. Weinstock
J Natl Cancer Inst 2008 100: 1223-1232. [Abstract] [Full Text] [PDF]

SDHB—A Gene for All Tumors?
Charis Eng
J Natl Cancer Inst 2008 100: 1193-1195. [Extract] [Full Text] [PDF]

Speeding up the Evaluation of New Agents in Cancer
Mahesh K. B. Parmar, Friederike. M.-S. Barthel, Matthew Sydes, Ruth Langley, Rick Kaplan, Elizabeth Eisenhauer, Mark Brady, Nicholas James, Michael A. Bookman, Ann-Marie Swart, Wendi Qian, and Patrick Royston
J Natl Cancer Inst 2008 100: 1204-1214. [Abstract] [Full Text] [PDF]